2025 annual financial data
Tango Therapeutics 2025 Operating margin
Direct answer
Operating margin was -178.39%.
Operating income was -111,289,000 USD and net income was -101,594,000 USD.
Operating cash flow was -138,886,000 USD.
Get free Tango Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 62,384,000 USD
- Operating income
- -111,289,000 USD
- Net income
- -101,594,000 USD
- Operating cash flow
- -138,886,000 USD